These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 6833525)

  • 1. Plasma cortisol values after dexamethasone in depressed inpatients.
    Peselow ED; Serby M; Wolkin A; Deutsch SI; Fricchione G; Rotrosen JP
    J Clin Psychopharmacol; 1983 Feb; 3(1):45-6. PubMed ID: 6833525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cortisol secretion rate 16 hours after dexamethasone administration in patients with major depression].
    Wichowicz H; Landowski J; Sowiński P
    Psychiatr Pol; 1997; 31(4):471-7. PubMed ID: 9527690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of dexamethasone (2 mg) and plasma cortisol hypersecretion in depressive illness: clinical and neuroendocrine parameters.
    Asnis GM; Halbreich U; Sachar EJ; Nathan RS; Davies M; Novacenko H; Ostrow LC; Endicott J; Puig-Antich J
    Psychopharmacol Bull; 1982 Oct; 18(4):122-6. PubMed ID: 7156272
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone resistance and cortisol secretion in depressive illness.
    Vandewalle J; Charles G; Mardens Y; Mendlewicz J
    Biol Psychiatry; 1983 Mar; 18(3):385-9. PubMed ID: 6838943
    [No Abstract]   [Full Text] [Related]  

  • 5. The dexamethasone suppression test in an elderly population.
    Tourigny-Rivard MF; Raskind M; Rivard D
    Biol Psychiatry; 1981 Dec; 16(12):1177-84. PubMed ID: 6891606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol suppression index: a new approach to interpreting the DST in depression.
    Bernstein JP; Chung SY; Avila KS
    J Clin Psychiatry; 1982 Dec; 43(12):476-8. PubMed ID: 7161249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: a multivariate analysis.
    Hubain PP; Staner L; Dramaix M; Kerkhofs M; Papadimitriou G; Mendlewicz J; Linkowski P
    Biol Psychiatry; 1998 Feb; 43(3):220-9. PubMed ID: 9494704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive psychomotor disturbance, cortisol, and dexamethasone.
    Mitchell P; Hadzi-Pavlovic D; Parker G; Hickie I; Wilhelm K; Brodaty H; Boyce P
    Biol Psychiatry; 1996 Nov; 40(10):941-50. PubMed ID: 8915553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cortisol suppressing effect of dexamethasone and oxazepam in depressed patients; significance of spontaneous levels and interindividual distribution.
    Christensen P; Gram LF; Lolk A; Kragh-Sørensen P
    J Affect Disord; 1987; 13(3):273-8. PubMed ID: 2960720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in depressed patients: clinical and biochemical aspects.
    Holsboer F
    J Steroid Biochem; 1983 Jul; 19(1A):251-7. PubMed ID: 6887861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cortisol suppression index.
    Clower CG
    J Clin Psychiatry; 1983 Jul; 44(7):275. PubMed ID: 6863229
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA; Greden JF; Tarika J; Carroll BJ
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol suppression index.
    Bernstein JP; Chung SY; Avila KS
    Am J Psychiatry; 1982 Dec; 139(12):1645. PubMed ID: 7149073
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexamethasone for depression.
    Wolkowitz OM; Reus VI; Manfredi F; Chan T; Ormiston S; Johnson R
    Am J Psychiatry; 1996 Aug; 153(8):1112; author reply 1112-3. PubMed ID: 8678190
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms.
    Reus VI
    Biol Psychiatry; 1982 Mar; 17(3):317-26. PubMed ID: 7082699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference by carbamazepine with the dexamethasone suppression test.
    Privitera MR; Greden JF; Gardner RW; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1982 May; 17(5):611-20. PubMed ID: 7093397
    [No Abstract]   [Full Text] [Related]  

  • 18. The dexamethasone suppression test as an indication of depression in patients with mental retardation.
    Mattes JA; Amsell L
    Am J Ment Retard; 1993 Nov; 98(3):354-9. PubMed ID: 7904820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients.
    Kiive E; Maaroos J; Shlik J; Tõru I; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1007-13. PubMed ID: 15380861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of the dexamethasone suppression test in depression.
    Charles G; Wilmotte J; Quenon M; Mendlewicz J
    Biol Psychiatry; 1982 Jul; 17(7):845-8. PubMed ID: 7115835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.